Todd W Bauer Selected Research

Todd W Bauer Research Topics

Disease

68	Neoplasms (Cancer) 03/2024 - 08/2002
29	Cholangiocarcinoma 02/2024 - 11/2014
23	Pancreatic Neoplasms (Pancreatic Cancer) 03/2024 - 07/2005
18	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2005
8	Adenocarcinoma 03/2024 - 01/2011
5	Infections 01/2018 - 05/2005
4	Lymphatic Metastasis 03/2023 - 12/2018
4	Colorectal Neoplasms (Colorectal Cancer) 02/2013 - 04/2005
4	Carcinoma (Carcinomatosis) 11/2007 - 01/2005
2	Margins of Excision 03/2024 - 01/2024
2	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 02/2019
2	Heart Arrest (Cardiac Arrest) 11/2018 - 01/2016
2	Sepsis (Septicemia) 11/2018 - 06/2015
2	Malnutrition (Nutritional Deficiencies) 11/2018 - 01/2016
2	Embolism (Embolus) 11/2018 - 01/2016
2	Liver Neoplasms (Liver Cancer) 10/2018 - 11/2016
2	Klatskin Tumor 01/2018 - 10/2012
2	Neoplasm Micrometastasis 01/2018 - 01/2016
2	Pancreatic Fistula (Pancreatic Fistulas) 01/2018 - 05/2011
2	Breast Neoplasms (Breast Cancer) 01/2016 - 03/2002
2	Cholangitis 07/2015 - 11/2014
2	Melanoma (Melanoma, Malignant) 04/2003 - 08/2002
1	Hypoxia (Hypoxemia) 03/2024
1	Inflammation (Inflammations) 01/2024
1	Confusion (Bewilderment) 07/2023
1	Postoperative Pain 11/2022

Drug/Important Bio-Agent (IBA)

7	Gemcitabine FDA Link 07/2023 - 09/2005
6	AntigensIBA 03/2024 - 01/2018
5	CarbohydratesIBA 03/2024 - 01/2018
4	LigandsIBA 01/2021 - 04/2005
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2018 - 02/2013
4	Insulin-Like Growth Factor I (IGF-1)IBA 10/2007 - 05/2005
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2006 - 04/2005
3	Carcinoembryonic AntigenIBA 03/2024 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 03/2024 - 07/2005
3	AntibodiesIBA 01/2023 - 07/2014
3	AlbuminsIBA 01/2023 - 01/2018
3	Monoclonal AntibodiesIBA 02/2018 - 09/2005
3	trametinibIBA 01/2016 - 02/2013
3	ErbB Receptors (EGF Receptor)IBA 07/2014 - 01/2005
3	Phosphotransferases (Kinase)IBA 02/2013 - 01/2005
3	IGF Type 1 Receptor (IGF 1 Receptor)IBA 10/2007 - 09/2005
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 07/2006 - 05/2005
3	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2006 - 04/2005
2	Immunoconjugates (Immunoconjugate)IBA 03/2024 - 02/2018
2	Peptides (Polypeptides)IBA 03/2024 - 01/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2024 - 05/2005
2	Culture MediaIBA 01/2024 - 01/2021
2	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2023 - 12/2021
2	Hormones (Hormone)IBA 12/2023 - 12/2018
2	BilirubinIBA 01/2023 - 04/2020
2	Opioid Analgesics (Opioids)IBA 11/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2011
2	Tumor Biomarkers (Tumor Markers)IBA 08/2020 - 10/2018
2	Indicators and Reagents (Reagents)IBA 09/2019 - 03/2002
2	Lapatinib (GW572016)FDA Link 07/2014 - 02/2013
2	Capecitabine (Xeloda)FDA Link 01/2014 - 03/2011
2	tyrosine receptor (receptor, tyrosine)IBA 02/2013 - 07/2005
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2013 - 01/2005
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2008 - 08/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2008 - 04/2003
2	Coloring Agents (Dyes)IBA 09/2006 - 03/2002
2	Catalytic RNA (Ribozymes)IBA 07/2006 - 05/2005
2	Vascular Endothelial Growth Factor BIBA 01/2006 - 07/2005
2	Urokinase Plasminogen Activator ReceptorsIBA 09/2005 - 05/2005
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 09/2005 - 05/2005
2	Melphalan (Alkeran)FDA LinkGeneric 04/2003 - 08/2002
1	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 03/2024
1	Complementary DNA (cDNA)IBA 03/2024
1	Chimeric Antigen ReceptorsIBA 03/2024
1	Histones (Histone)IBA 03/2024
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 03/2024
1	Histone DemethylasesIBA 03/2024
1	Histone MethyltransferasesIBA 03/2024
1	MelatoninIBA 12/2023
1	NF-kappa B (NF-kB)IBA 09/2023
1	pembrolizumabIBA 09/2023
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 01/2023
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2023
1	Adenosine A2B ReceptorIBA 01/2023
1	Adenosine (Adenocard)FDA LinkGeneric 01/2023
1	Adenosine Triphosphate (ATP)IBA 01/2023
1	TeaIBA 11/2022
1	Floxuridine (FUdR)FDA LinkGeneric 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	ChromatinIBA 01/2022

Therapy/Procedure

19	Therapeutics 03/2024 - 01/2005
19	Hepatectomy 02/2024 - 10/2012
11	Lymph Node Excision (Lymph Node Dissection) 01/2024 - 08/2009
8	Drug Therapy (Chemotherapy) 03/2024 - 01/2005
5	Adjuvant Chemotherapy 03/2023 - 10/2017
4	Neoadjuvant Therapy 09/2023 - 01/2014
4	Pancreaticoduodenectomy 11/2022 - 06/2015
3	Length of Stay 01/2024 - 01/2018
3	Pancreatectomy 11/2018 - 05/2011
2	Blood Transfusion (Blood Transfusions) 01/2024 - 01/2016
2	Radiofrequency Ablation 02/2019 - 11/2014
2	Immunotherapy 01/2018 - 01/2016
1	Operative Time 01/2024
1	Analgesia 11/2022